Source: American Journal of Respiratory and Critical Care Medicine. Unidades: FM, FMRP, FORP
Subjects: NERVO HIPOGLOSSO, MÚSCULOS FARÍNGEOS, APNEIA DO SONO TIPO OBSTRUTIVA
ABNT
CURADO, Thomaz Fleury et al. Designer receptors exclusively activated by designer drugs approach to treatment of sleep-disordered breathing. American Journal of Respiratory and Critical Care Medicine, v. 203, n. 1, p. 102-110, 2021Tradução . . Disponível em: https://doi.org/10.1164/rccm.202002-0321OC. Acesso em: 16 fev. 2026.APA
Curado, T. F., Pho, H., Freire, C., Amorim, M. R., Bonaventura, J., Kim, L. J., et al. (2021). Designer receptors exclusively activated by designer drugs approach to treatment of sleep-disordered breathing. American Journal of Respiratory and Critical Care Medicine, 203( 1), 102-110. doi:10.1164/rccm.202002-0321OCNLM
Curado TF, Pho H, Freire C, Amorim MR, Bonaventura J, Kim LJ, Lee R, Cabassa ME, Streeter SR, Branco LG de S, Sennes LU, Fishbein K, Spencer RG, Schwartz AR, Brennick MJ, Michaelides M, Fuller DD, Polotsky VY. Designer receptors exclusively activated by designer drugs approach to treatment of sleep-disordered breathing [Internet]. American Journal of Respiratory and Critical Care Medicine. 2021 ; 203( 1): 102-110.[citado 2026 fev. 16 ] Available from: https://doi.org/10.1164/rccm.202002-0321OCVancouver
Curado TF, Pho H, Freire C, Amorim MR, Bonaventura J, Kim LJ, Lee R, Cabassa ME, Streeter SR, Branco LG de S, Sennes LU, Fishbein K, Spencer RG, Schwartz AR, Brennick MJ, Michaelides M, Fuller DD, Polotsky VY. Designer receptors exclusively activated by designer drugs approach to treatment of sleep-disordered breathing [Internet]. American Journal of Respiratory and Critical Care Medicine. 2021 ; 203( 1): 102-110.[citado 2026 fev. 16 ] Available from: https://doi.org/10.1164/rccm.202002-0321OC
